Background:Proprotein convertase subtilisin/kexin type 9 (PCSK9) is also known as NARC1 (neural apoptosis regulated convertase), is a newly identified subtilase belonging to the peptidase S8 subfamily.
Mouse PCSK9 is synthesized as a soluble zymogen, and undergoes autocatalytic intramolecular processing in the endoplasmic reticulum, resulting in the cleavage of its propeptide that remains associated with the secreted active enzyme with a broad alkaline pH optimum.
This protein plays a major regulatory role in cholesterol homeostasis.
PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation.
PCSK9 may also have a role in the differentiation of cortical neurons.
Mutations in this gene have been associated with a rare form of autosomal dominant familial hypercholesterolemia (HCHOLA3).
仕様
サイズ:100ug
Source:Mouse PCSK9, His Tag (PC9-M5228) is expressed from human 293 cells (HEK293). It contains AA Gln 35 - Gln 694 (Accession # AAH38085.1).
Molecule:PCSK9
Synonyms:PCSK9,FH3,HCHOLA3,LDLCQ1,NARC1,PC9
Species:Mouse
Tag:His Tag
Expression Systems:HEK293
Expression Rigeion:Gln 35 - Gln 694
Conjugate:Unconjugated
Accession:AAH38085.1
Molecular Weight:13.9 kDa and 58.2 kDa
Characteristics:This protein carries a polyhistidine tag at the C-terminus. This protein undergoes autocatalytic cleavage to release the pro-peptide and mature chain. The pro-peptide and mature chain are associated through non‑covalent interactions and with a calculated MW of 13.9 kDa and 58.2 kDa respectively. The protein migrates as 17 kDa and 65 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level:Less than 1.0 EU per ug by the LAL method.